Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis

American Journal of Human Genetics

Volumn 67, Issue 2, 2000, Pages 417-431

  Goldberg, Eleonora K ^a   Glendening, J Michael ^a   Karanjawala, Zarir ^a   Sridhar, Anjali ^a   Walker, Graeme J ^a,b   Hayward, Nicholas K ^b   Rice, Andrew J ^a   Kurera, Yasmine ^a   Tebha, Jane W ^a   Fountain, Jane W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11; CONTROLLED STUDY; DNA FLANKING REGION; GENE DELETION; GENE FREQUENCY; GENE MAPPING; GENETIC MARKER; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; MELANOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033858241     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302999     Document Type: Article

References (91)

1. A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus. 11q22.2-q23.3
2. Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene
3. Genomic organization and precise physical location of protein phosphatase 2A regulatory subunit A beta isoform gene on chromosome band 11q23
4. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23
5. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
6. A high-resolution STS, EST, and gene-based physical map of the hereditary paraganglioma region on chromosome 11q23
7. Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma
8. On the oncodevelopmental role of human imprinted genes
9. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
10. Long homozygous chromosomal segments in reference families from the Centre d'Etude du Polymorphisme Humain
11. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
12. CDKN2A/p16 is inactivated in most melanoma cell lines
13. Positional cloning of the gene for multiple endocrine neoplasia-type 1
14. Localization of a putative liver tumor suppressor locus to a 950-kb region of human 11p11.2-p12 using rat liver tumor microcell hybrid cell lines
15. Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer
16. Role of TCL1 and ALL1 in human leukemias and development
17. Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer
18. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer
19. A comprehensive genetic map of the human genome based on 5,264 microsatellites
20. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2
21. Transfection of glioma cells with the neural-cell adhesion molecule NCAM: Effect on glioma-cell invasion and growth in vivo
22. Loss of p16(INK4a) and p15(INK4b) genes, as well as neighboring 9p21 markers, in sporadic melanoma
23. Application of cell lines for identification of genes implicated in breast cancer
24. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer
25. Genetic factors
26. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis
27. Low frequency of p16/CDKN2A methylation in sporadic melanoma: Comparative approaches for methylation analysis of primary tumors
28. Loss of heterozygosity at chromosome 11 in breast cancer: Association of prognostic factors with genetic alterations
29. Loss of heterozygosity in sporadic human breast carcinoma: A common region between 11q22 and 11q23.3
30. Loss of heterozygosity in cervical carcinoma: Subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24
31. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and anti-tumoral efficacy that can be augmented by standard chemotherapeutic agents
32. Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma
33. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma
34. Genetic heterogeneity of chromosome 11 associated with tumorigenicity in HeLa D98-OR cells
35. A variant form of ETS1 induces apoptosis in human colon cancer cells
36. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma
37. Allelic losses in human chromosome 11 in lung cancers
38. A radiation hybrid map of 506 STS markers spanning human chromosome 11
39. A cell cycle regulator potentially involved in the genesis of many tumor types
40. Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer
41. 11q deletions in human colorectal carcinomas: Cytogenetics and restriction fragment length polymorphism analysis
42. Beyond DNA cross-linking: History and prospects of DNA-targeted cancer treatment
43. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers
44. Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM
45. Array of hope
46. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer
47. The p42 variant of ETS1 protein rescues defective Fas-induced apoptosis in colon carcinoma cells
48. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines
49. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients
50. Maternal uniparental disomy of chromosome 14 confined to an interstitial segment (14q23-14q24.2)
51. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15
52. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6
53. Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome 11
54. Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23
55. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
56. Preferential chromosome 11q and/or 17q aberrrations in short-term cultures of metastatic melanoma in resections from human brain
57. Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q
58. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: Identification of a new region at 11q23.3
59. Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma
60. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells
61. Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: Evidence for common founders and independent mutations
62. Relaxation of imprinted genes in cancer
63. Genomic organization of the ATM locus involved in ataxia- telangiectasia
64. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions
65. A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region
66. A malignant melanoma tumor suppressor on human chromosome 11
67. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma
68. Functional localization of a melanoma tumor suppressor gene to a small (2 Mb) region on 11q23
69. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25
70. A single ataxia telangiectasia gene with a product similar to PI-3 kinase
71. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis
72. Deletion mapping of chromosome 11 in carcinoma of the bladder
73. Novel approaches to linkage mapping
74. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
75. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas
76. Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers
77. Allele loss on chromosome 11 q and microsatellite instability in malignant melanoma
78. Loss of heterozygosity on chromosome 11q in breast cancer
79. Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma
80. Localization of Jacobsen syndrome breakpoints on a 10-Mb physical map of distal chromosome 11q
81. Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer
82. A high-density microsatellite map of the ataxia-telangiectasia locus
83. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets
84. Functional reassessment of p16 variants using a transfection-based assay
85. A genetic model of melanoma tumorigenesis based on allelic losses
86. Alterations of the PPP2R1B gene in human lung and colon cancer
87. Fine resolution and isolation of a putative suppressor oncogene active in human lung cancer
88. Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer
89. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis
90. Comparisons of features of human lung cancer cell lines and their corresponding tumors